Double-blind, placebo-controlled study of L-acetylcarnitine for the treatment of hyperactive behavior in fragile X syndrome.
Torrioli
M G
MG
Vernacotola
S
S
Mariotti
P
P
Bianchi
E
E
Calvani
M
M
De Gaetano
A
A
Chiurazzi
P
P
Neri
G
G
D000108:Acetylcarnitine / Q000627:therapeutic use*; D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000209:etiology; D002648:Child; D004311:Double-Blind Method; D005600:Fragile X Syndrome / Q000150:complications*; D006801:Humans; D008297:Male; D018697:Nootropic Agents / Q000627:therapeutic use*; D013223:Statistics as Topic; D016896:Treatment Outcome
D018697:Nootropic Agents; D000108:Acetylcarnitine